Literature DB >> 25449657

Quantitative high-throughput screening data analysis: challenges and recent advances.

Keith R Shockley1.   

Abstract

In vitro HTS holds much potential to advance drug discovery and provide cell-based alternatives for toxicity testing. In quantitative HTS, concentration-response data can be generated simultaneously for thousands of different compounds and mixtures. However, nonlinear modeling in these multiple-concentration assays presents important statistical challenges that are not problematic for linear models. The uncertainty of parameter estimates obtained from the widely used Hill equation model can be extremely large when using standard designs. Failure to properly consider standard errors of these parameter estimates would greatly hinder chemical genomics and toxicity testing efforts. In this light, optimal study designs should be developed to improve nonlinear parameter estimation; or alternative approaches with reliable performance characteristics should be used to describe concentration-response profiles. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2014        PMID: 25449657      PMCID: PMC4375054          DOI: 10.1016/j.drudis.2014.10.005

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  23 in total

1.  A comprehensive statistical analysis of predicting in vivo hazard using high-throughput in vitro screening.

Authors:  Russell S Thomas; Michael B Black; Lili Li; Eric Healy; Tzu-Ming Chu; Wenjun Bao; Melvin E Andersen; Russell D Wolfinger
Journal:  Toxicol Sci       Date:  2012-04-26       Impact factor: 4.849

Review 2.  Critical review of the role of HTS in drug discovery.

Authors:  Ricardo Macarron
Journal:  Drug Discov Today       Date:  2006-04       Impact factor: 7.851

3.  Toxicology. Transforming environmental health protection.

Authors:  Francis S Collins; George M Gray; John R Bucher
Journal:  Science       Date:  2008-02-15       Impact factor: 47.728

4.  Analysis of nonlinear regression models: a cautionary note.

Authors:  Shyamal D Peddada; Joseph K Haseman
Journal:  Dose Response       Date:  2006-05-01       Impact factor: 2.658

5.  Statistical properties of an early stopping rule for resampling-based multiple testing.

Authors:  Hui Jiang; Julia Salzman
Journal:  Biometrika       Date:  2012-10-03       Impact factor: 2.445

6.  Incorporating biological, chemical, and toxicological knowledge into predictive models of toxicity.

Authors:  David J Dix; Keith A Houck; Richard S Judson; Nicole C Kleinstreuer; Thomas B Knudsen; Matthew T Martin; David M Reif; Ann M Richard; Imran Shah; Nisha S Sipes; Robert J Kavlock
Journal:  Toxicol Sci       Date:  2012-09-14       Impact factor: 4.849

7.  Pharmacodynamic models: parameterizing the hill equation, Michaelis-Menten, the logistic curve, and relationships among these models.

Authors:  Russell Reeve; J Rick Turner
Journal:  J Biopharm Stat       Date:  2013-05       Impact factor: 1.051

8.  Using weighted entropy to rank chemicals in quantitative high-throughput screening experiments.

Authors:  Keith R Shockley
Journal:  J Biomol Screen       Date:  2013-09-20

9.  Inconsistency in large pharmacogenomic studies.

Authors:  Benjamin Haibe-Kains; Nehme El-Hachem; Nicolai Juul Birkbak; Andrew C Jin; Andrew H Beck; Hugo J W L Aerts; John Quackenbush
Journal:  Nature       Date:  2013-11-27       Impact factor: 49.962

10.  Design of experiments for the precise estimation of dose-response parameters: the Hill equation.

Authors:  M Bezeau; L Endrenyi
Journal:  J Theor Biol       Date:  1986-12-21       Impact factor: 2.691

View more
  9 in total

1.  A Data Analysis Pipeline Accounting for Artifacts in Tox21 Quantitative High-Throughput Screening Assays.

Authors:  Jui-Hua Hsieh; Alexander Sedykh; Ruili Huang; Menghang Xia; Raymond R Tice
Journal:  J Biomol Screen       Date:  2015-04-22

2.  Identification of small molecule inhibitors targeting the SMARCA2 bromodomain from a high-throughput screening assay.

Authors:  Tian Lu; Jun-Chi Hu; Wen-Chao Lu; Jie Han; Hong Ding; Hao Jiang; Yuan-Yuan Zhang; Li-Yan Yue; Shi-Jie Chen; Hua-Liang Jiang; Kai-Xian Chen; Hui-Fang Chai; Cheng Luo
Journal:  Acta Pharmacol Sin       Date:  2018-05-24       Impact factor: 6.150

3.  Accounting for Artifacts in High-Throughput Toxicity Assays.

Authors:  Jui-Hua Hsieh
Journal:  Methods Mol Biol       Date:  2022

Review 4.  Rethinking drug design in the artificial intelligence era.

Authors:  Petra Schneider; W Patrick Walters; Alleyn T Plowright; Norman Sieroka; Jennifer Listgarten; Robert A Goodnow; Jasmin Fisher; Johanna M Jansen; José S Duca; Thomas S Rush; Matthias Zentgraf; John Edward Hill; Elizabeth Krutoholow; Matthias Kohler; Jeff Blaney; Kimito Funatsu; Chris Luebkemann; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2019-12-04       Impact factor: 84.694

5.  Estimating Potency in High-Throughput Screening Experiments by Maximizing the Rate of Change in Weighted Shannon Entropy.

Authors:  Keith R Shockley
Journal:  Sci Rep       Date:  2016-06-15       Impact factor: 4.379

6.  Chemoinformatic Analysis of Psychotropic and Antihistaminic Drugs in the Light of Experimental Anti-SARS-CoV-2 Activities.

Authors:  Bruno O Villoutreix; Rajagopal Krishnamoorthy; Ryad Tamouza; Marion Leboyer; Philippe Beaune
Journal:  Adv Appl Bioinform Chem       Date:  2021-04-12

7.  Comparison of Points of Departure for Health Risk Assessment Based on High-Throughput Screening Data.

Authors:  Salomon Sand; Fred Parham; Christopher J Portier; Raymond R Tice; Daniel Krewski
Journal:  Environ Health Perspect       Date:  2016-07-06       Impact factor: 9.031

8.  Dose-Related Severity Sequence, and Risk-Based Integration, of Chemically Induced Health Effects.

Authors:  Salomon Sand; Roland Lindqvist; Dietrich von Rosen; Nils-Gunnar Ilbäck
Journal:  Toxicol Sci       Date:  2018-09-01       Impact factor: 4.849

9.  Uncertainty quantification in ToxCast high throughput screening.

Authors:  Eric D Watt; Richard S Judson
Journal:  PLoS One       Date:  2018-07-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.